Viewing StudyNCT06390774



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06390774
Status: RECRUITING
Last Update Posted: 2024-04-30
First Post: 2024-04-08

Brief Title: A Study to Evaluate the Safety Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
Sponsor: Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization: Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-04
Start Date Type: ESTIMATED
Primary Completion Date: 2026-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-02
Completion Date Type: ESTIMATED
First Submit Date: 2024-04-08
First Submit QC Date: April 24 2024
Study First Post Date: 2024-04-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-16
Last Update Post Date: 2024-04-30
Last Update Post Date Type: ACTUAL